BIIB
Biogen Inc
Price:  
134.21 
USD
Volume:  
1,137,576.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen Intrinsic Value

51.50 %
Upside

What is the intrinsic value of Biogen?

As of 2025-07-14, the Intrinsic Value of Biogen Inc (BIIB) is 203.37 USD. This Biogen valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 134.21 USD, the upside of Biogen Inc is 51.50%.

The range of the Intrinsic Value is 161.85 - 271.71 USD

Is Biogen undervalued or overvalued?

Based on its market price of 134.21 USD and our intrinsic valuation, Biogen Inc (BIIB) is undervalued by 51.50%.

134.21 USD
Stock Price
203.37 USD
Intrinsic Value
Intrinsic Value Details

Biogen Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 161.85 - 271.71 203.37 51.5%
DCF (Growth 10y) 177.28 - 287.51 219.18 63.3%
DCF (EBITDA 5y) 189.27 - 266.41 229.66 71.1%
DCF (EBITDA 10y) 196.92 - 282.04 238.86 78.0%
Fair Value 50.48 - 50.48 50.48 -62.39%
P/E 134.66 - 251.84 182.94 36.3%
EV/EBITDA 212.58 - 310.96 254.18 89.4%
EPV 174.62 - 245.18 209.90 56.4%
DDM - Stable 69.18 - 146.22 107.70 -19.8%
DDM - Multi 84.61 - 145.75 107.66 -19.8%

Biogen Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 19,665.79
Beta 0.51
Outstanding shares (mil) 146.53
Enterprise Value (mil) 23,365.29
Market risk premium 4.60%
Cost of Equity 9.21%
Cost of Debt 4.28%
WACC 7.87%